• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY GMBH CARDIOHELP; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY GMBH CARDIOHELP; CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS Back to Search Results
Model Number CARDIOHELP-I
Device Problems Device Sensing Problem (2917); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Insufficient Information (4580); No Clinical Signs, Symptoms or Conditions (4582)
Event Date 10/23/2022
Event Type  Death  
Event Description
Customer reported a defective atrial bubble sensor while patient was on ecmo.The atrial bubble sensor alarm was triggered which stopped the flow.The lines were then clamped and the dearing protocol was performed.Then the venous bubble alarm was triggered with no visible bubble and was reset.Estimated time of ecmo flow interruption was about 1-2 minutes.The patient expired.Complaint id: (b)(4).
 
Manufacturer Narrative
The investigation is ongoing.So far the cardiohelp was inspected and it works fine with no error messages.Also the flow bubble sensor was inspected and it works fine and is not defective.Further information has been requested but has not yet been received.A medical review was requested and a follow-up emdr will be submitted when additional information becomes available.
 
Manufacturer Narrative
It was reported that one venous bubble alarm and two arterial bubble alarms were triggered without any visible air bubbles.The event occurred during treatment.No intervention was set for the redundant venous bubble sensor.The intervention of the mandatory arterial air bubble sensor triggered the pump stop twice as per design to prevent complications of air embolism.After each pump stop the customer manually clamped the lines, aspirated from the pre oxygenator pigtail and inspected the circuit for air.No air was seen on aspiration.The treatment was continues about 1 minute and 46 seconds after the first pump stop.The patient did die many days later, according to the customer this was not at all related to this incident.The clinic did not elaborate on the cause of death.A getinge field service technician (fst) was sent for investigation on 2022-10-27.The cardiohelp and both the venous and the arterial bubble sensors were tested and no device malfunction was identified during the service.No parts were replaced.The fst performed safety, calibration, and functionality checks to factory specifications.All function tests are passed.According to the log file review performed by getinge life cycle engineering for the reported date of event 2022-10-23 at 17:48:37 (cardiohelp time), the venous bubble was detected 3 seconds before the first arterial bubble alarm was logged at 17:48:37.No intervention was set by the user for the venous bubble monitoring, therefore only the arterial bubble detection stopped the pump.The operator reset at 17:49:49 the arterial bubble intervention leading to a pump start (downtime.1 min 12 sec) shortly afterwards (2 sec) a second arterial bubble alarm was logged with a downtime of 34 sec.In two triggered pump stops there was in total no flow for 1 minute and 46 seconds (1 min 12 sec and 34 sec downtime).A medical review was performed by getinge medical affairs on 2022-12-05 with the following conclusion: the review of the patient outcome and any association with this sequence of events is challenging given there is a paucity of clinical information.However, a review of the customer product complaint single report, follow-up correspondence, service report, and logs files provide reasonable insight into the most likely root cause of the event reported based on the available information.The most likely root cause of sequential air bubble alarms on both venous bubble sensor and arterial flow bubble sensor appears to be related to the administration of albumin via the central line during therapy.As described in the evaluation, a rapid change in the nature of the fluid transiting the acoustic window in an ultrasonic bubble sensor can trigger a false positive bubble.The log file alarms and the reported concurrent administration of albumin support this mechanism.The service report indicated the system and bubble sensors were functioning to specification.The clinician reported no air was visualized during the de-airing protocol.In sum, this supports the conclusion this occurrence was a ¿false positive alarm¿ triggered by the above mechanism.The safety system intervention and the observed occurrence are known limits of the technology and sensitivity of ultrasonic sensors.The transmission of air into the circuit by any means is always possible but the available information does not support this conclusion given the description provided by the end user.Although the patient outcome is very unfortunate, based on the available information and associated self-reporting by the clinic, no association between the patient outcome and this sequence of events can be suggested.The cardiohelp device and safety systems functioned within specification.The false positive alarm proposed is a known limitation of state of the art technology.A determination of whether a use error occurred is challenging.Rapid administration of fluids (colloids/crystalloids) is a common and necessary clinical intervention for patients undergoing extracorporeal support.False positive alarms can occur based on the limitations of the technology as described above.It appears that the event was expertly managed by the clinician and is consistent with best practice, training, and the device cautions and warnings in the instructions for use (gmbh, heart lung support system cardiohelp system instruction guidelines, 2022), (gmbh & maquet cardiopulmonary , hls cannulae set instructions for use |2.6 |g-139|05).
 
Event Description
It was reported that one venous bubble alarm and two arterial bubble alarms were triggered without any visible air bubbles.The event occurred during treatment.No intervention was set for the redundant venous bubble sensor.The intervention of the mandatory arterial air bubble sensor triggered the pump stop twice as per design to prevent complications of air embolism.After each pump stop the customer manually clamped the lines, aspirated from the pre oxygenator pigtail and inspected the circuit for air.No air was seen on aspiration.The treatment was continues about 1 minute and 46 seconds after the first pump stop.The patient did die many days later, according to the customer this was not at all related to this incident.The clinic did not elaborate on the cause of death.Complaint id: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CARDIOHELP
Type of Device
CONSOLE, HEART-LUNG MACHINE, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY GMBH
neue rottenburger strasse 37
hechingen
Manufacturer (Section G)
JULIA KAPFENBERGER
neue rottenburger strasse 37
hechingen
Manufacturer Contact
neue rottenburger strasse 37
hechingen 
MDR Report Key15713900
MDR Text Key302834151
Report Number3008355164-2022-00028
Device Sequence Number1
Product Code DTQ
Combination Product (y/n)N
PMA/PMN Number
K133598
Number of Events Reported1
Summary Report (Y/N)N
Report Source Distributor
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 12/13/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberCARDIOHELP-I
Device Catalogue Number701048012
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA12/13/2022
Distributor Facility Aware Date11/16/2022
Device Age2 YR
Event Location Hospital
Date Report to Manufacturer12/13/2022
Initial Date Manufacturer Received Not provided
Initial Date FDA Received11/02/2022
Supplement Dates Manufacturer Received11/16/2022
Supplement Dates FDA Received12/13/2022
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured06/24/2020
Is the Device Single Use? No
Type of Device Usage Reuse
Patient Sequence Number1
Patient Outcome(s) Death;
-
-